Amneal Pharmaceuticals, Inc.
AMRX
$17.25
$0.201.17%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 57.66M | 62.26M | 35.08M | 2.37M | 22.42M |
| Total Depreciation and Amortization | 47.80M | 43.19M | 49.23M | 54.07M | 60.11M |
| Total Amortization of Deferred Charges | 4.06M | 3.89M | 3.72M | 5.03M | 6.88M |
| Total Other Non-Cash Items | 60.74M | 54.00M | 54.59M | 107.72M | 29.52M |
| Change in Net Operating Assets | -191.51M | -190.08M | -12.29M | -50.74M | -35.11M |
| Cash from Operations | -21.24M | -26.74M | 130.32M | 118.45M | 83.82M |
| Capital Expenditure | -45.59M | -13.86M | -43.17M | -15.05M | -26.50M |
| Sale of Property, Plant, and Equipment | -- | -- | 715.00K | 0.00 | 855.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -77.15M | -7.85M | -3.00M | -7.41M | -900.00K |
| Cash from Investing | -122.74M | -21.71M | -45.45M | -22.46M | -26.55M |
| Total Debt Issued | 99.49M | 135.18M | 795.00K | 2.70B | 0.00 |
| Total Debt Repaid | -6.19M | -140.84M | -6.12M | -2.55B | -15.55M |
| Issuance of Common Stock | 42.00K | 38.00K | 553.00K | 653.00K | 685.00K |
| Repurchase of Common Stock | -176.00K | -44.31M | -321.00K | -129.00K | -189.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -13.81M | -9.13M | -5.02M | -87.10M | -26.64M |
| Cash from Financing | 79.36M | -59.06M | -10.12M | 59.44M | -41.69M |
| Foreign Exchange rate Adjustments | -164.00K | -1.02M | -209.00K | -694.00K | -307.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -64.79M | -108.53M | 74.53M | 154.74M | 15.28M |